Transfusion management in multiple myeloma patients receiving daratumumab: Experience of a single tertiary care centre

2020 ◽  
Vol 59 (2) ◽  
pp. 102658
Author(s):  
Pilar Solves ◽  
Susana Tur ◽  
Mario Arnao ◽  
Carmen Freiria ◽  
Lara Dominguez ◽  
...  
2018 ◽  
Vol 24 (3) ◽  
pp. S50 ◽  
Author(s):  
Shruthi Ganeshappa Kodad ◽  
Heather Sutherland ◽  
Wasithep Limvorapitak ◽  
Yasser Abou Mourad ◽  
Michael J. Barnett ◽  
...  

Author(s):  
Sushil Kumar Shukla ◽  
Vikas Shrivastava ◽  
Mansi Kala ◽  
Kunal Das ◽  
Anuradha Kusum

Introduction: Multiple myeloma (MM) is a hemato-lymphoid malignancy of B-cell type. It occurs due to the accumulation of malignant monoclonal plasma cells. The exact incidence of MM in India is not well-known. The current study presented the clinical characteristics, radiological findings and laboratory findings of MM patients who were initially treated at the tertiary care centre, Dehradun, Uttarakhand (India). Material and methods: Retrospective analysis of the medical records of 123 consecutive patients with MM who were initially presented to Hemato-Oncology department during the period from January 2014 to December 2018.  Peripheral blood finding, bone marrow diagnosis, flow-cytometry analysis, serum protein and immunofixation electrophoresis finding, biochemical parameter, histo-pathological and cytological diagnosis, if any, urine examination finding and radiological examination of cases shall be compiled and tabulated. Diagnosis of symptomatic multiple myeloma was done based on The International Myeloma Working Group criteria for the diagnosis of MM. Result: The study included 123 cases of multiple myeloma with male: female ratio of 2:1, mean age of 59.88 ±11.08 years and range of 32-87 years. The back pain (n=106, 86.2%) was the common presenting complaint followed by inability to walk (n=90,73.2%). CT scan and/or MRI scan finding of MM patients, the lytic lesion was found in 107 patients (87%) and was found significant with its correlation with ISS/DS plus staging system (pvalue 0.013). The most location was dorso-lumbar spine (n=72, 67.28%) followed by skull (n=37, 34.58%) and ribs (n=19, 17.75%). Hemoglobin (Hb) analysis showed 92.7 % (n=114) cases were anemic with mostly had normocytic (n=95,77.2%). 62.6%(n=77) of cases showed rouleaux formation while 23.57% (n=29) cases were circulating plasmacytoid lymphocytes or plasma cells. The raised ESR values was found in 89.33% (n=67) of cases. Diagnosis of cases shows 99.2% (n=122) of cases diagnosed as secretory MM while 1 (0.8%) case diagnosed as non-secretory MM.  Conclusion: MM is a disease with a inconsistent clinical presentation with multiple system involvement. Younger age of disease onset is some noteworthy features of myeloma in Uttarakhand state of India. Bony pain associated with generalized weakness is the commonest presentation, normocytic normochromic anemia with rouleaux formation, raised ESR, raised total protein with hypoalbuminemia, hypercalcemia, presence of M band and presence of >10% plasma cell in bone marrow is clue to diagnosis in MM cases .  Keywords: Multiple Myeloma, Uttrakhand, Hemato-lymphoid malignancy


2019 ◽  
Vol 6 (34) ◽  
pp. 2328-2330
Author(s):  
Sunil Vitthalrao Jagtap ◽  
Swati Sunil Jagtap ◽  
Saswati Boral ◽  
Garima Agarwal

2017 ◽  
Vol 17 (1) ◽  
pp. e92
Author(s):  
Raajit Chanana ◽  
Manju Sengar ◽  
Hasmukh Jain ◽  
Navin Khattry ◽  
Bhausaheb Bagal ◽  
...  

2017 ◽  
Vol 23 ◽  
pp. 289
Author(s):  
Vineet Surana ◽  
Rajesh Khadgawat ◽  
Nikhil Tandon ◽  
Chandrashekhar Bal ◽  
Kandasamy Devasenathipathy

JMS SKIMS ◽  
2020 ◽  
Vol 23 (1) ◽  
pp. 48-49
Author(s):  
Javaid Ahmad Bhat ◽  
Shariq Rashid Masoodi

Apropos to the article by Dr Bali, titled “Mupirocin resistance in clinical isolates of methicillin-sensitive and resistant Staphylococcus aureus in a tertiary care centre of North India” (1), the authors have raised important issue of emerging antimicrobial resistance (AMR). Antimicrobial resistance is an increasingly serious threat to global public health that requires action across all government sectors and society. As per WHO, AMR lurks the effective prevention and management of an ever-increasing spectrum of infections caused by bacteria, parasites, fungi and viruses. Novel resistance mechanisms are emerging and spreading globally, threatening the man’s ability to treat common infectious diseases.


Sign in / Sign up

Export Citation Format

Share Document